| Biogen Inc. | 295.47 / -1.60% |
| Date/Time | 12/09 / 21:59 |
| Chg. / Chg.(%) | -4.81 / -1.60% |
| Bid | 295.39 / 1 |
| Ask | 295.90 / 1 |
| Open | 300.67 |
| Previous Close | 300.28 |
| High | 304.07 |
| Low | 295.47 |
| Volume [USD] | 11,211,759.99 |
| Volume [Units] | 64,709 |
| Price fixings | 346 |
| ISIN | US09062X1037 |
| Security | BIIB |
| Exchange | Cboe US |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 266.850 |  |
209 |
| Frankfurt | 267.0000 |  |
34 |
| Xetra | 266.30 | |
31 |
| Vienna Globa.. | 266.70 | |
0 |
| München | 267.00 | |
0 |
| Hamburg | 267.00 | |
0 |
| Düsseldorf | 265.60 | |
0 |
| Berlin | 266.50 | |
0 |
| Hannover | 267.00 | |
0 |
| Lang & Schwa.. | 266.300 | |
|
| gettex | 266.550 | |
|
| Stuttgart | 266.250 | |
|
| NASDAQ | 295.5500 | |
2,086,996 |
| IEX | 295.56 | |
76,234 |
| Cboe US | 295.47 | |
64,709 |
| London Inter.. | 297.76 | 2,402 | |
| SIX Swiss Ex.. | 232.00 | ||
| Mexico | 5,860.00 | 30 |
News
- Biogen stocks rise on new Alzheimer drug breakthrough
12/05/2019 / 19:26 - TeleTrader - Biogen Announces Positive Phase 2 Study Results for Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE)
12/03/2019 / 13:30 - GlobeNewswire - Wall Street opens mixed ahead of data
12/02/2019 / 15:30 - TeleTrader - Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares
11/26/2019 / 22:05 - GlobeNewswire - Biogen Presents Data Demonstrating Improved Gastrointestinal Tolerability With VUMERITY™ (diroximel fumarate) Compared to TECFIDERA® (dimethyl fumarate)
11/22/2019 / 13:30 - GlobeNewswire
Real-time